Information sources and cancer risk in subjects with Barrett's esophagus

Green, Bryan; Shaheen, Nicholas J; Noble, Marc; Schmitz, Sarah M; Wei, Jeffrey T; Provenzale, Dawn
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS228
Academic Journal
An abstract of the article "Information sources and cancer risk in subjects with Barrett's esophagus," by Bryan Green and colleagues is presented.


Related Articles

  • Radiofrequency ablation reduced risk for esophageal adenocarcinoma.  // Hem/Onc Today;6/25/2014, Vol. 15 Issue 12, p36 

    The article discusses the results of a multicenter, randomized trial conducted by K. Nadine Phoa, MD, and colleagues which appeared in a 2014 issue of the "Journal of the American Medical Association (JAMA)," revealing the decreased risk for high-grade esophageal adenocarcinoma that endoscopic...

  • CDX2 Overexpression in Barrett's Esophagus and Esophageal Adenocarcinoma. Streher, Leandro Almeida; Campos, Vinícius; da Silva Mazzini, Guilherme; Binato, Marcelo; Meurer, Luise; Edelweiss, Maria Isabel; Gurski, Richard Ricachenevsky // Journal of Cancer Therapy;Jun2014, Vol. 5 Issue 7, p657 

    Background: Patients with Barrett's esophagus have an increased risk of developing esophageal adenocarcinoma. Our purpose was to determine CDX2 expression in esophageal mucosa and establish a correlation between this marker and the progression of disease. Methods: We analyzed biopsies and...

  • Familial Barrett's Esophagus: Clues to Genetic Risks for Esophageal Adenocarcinoma. Rubenstein, Joel // Digestive Diseases & Sciences;Jun2011, Vol. 56 Issue 6, p1593 

    No abstract available.

  • Magnification Endoscopy and Chromoendoscopy in Evaluation of Specialized Intestinal Metaplasia in Barrett's Esophagus. Wasielica-Berger, Justyna; Baniukiewicz, Andrzej; Wroblewski, Eugeniusz; Chwiesko, Adam; Dabrowski, Andrzej // Digestive Diseases & Sciences;Jul2011, Vol. 56 Issue 7, p1987 

    Background: Specialized intestinal metaplasia (SIM) in Barrett's esophagus is a risk factor of esophageal adenocarcinoma. It often occurs focally and cannot be distinguished from surrounding columnar epithelium with conventional endoscopy. Aims: The purpose of this study was evaluation of...

  • Oral bisphosphonates a risk factor for oesophageal cancer?  // Reactions Weekly;1/17/2009, Issue 1235, p2 

    The article focuses on a recommendation on the inclusion of oral bisphosphonates as possible risk factors for esophageal cancer in studies. According to Diane Wysowski from the U.S. Food and Drug Administration (FDA), the FDA has been notified of 23 patients in the U.S. who have been diagnosed...

  • Barrett's oesophagus: size does matter. de Jonge, Pieter J. F.; Hvid-Jensen, Frederik // Gut;Feb2016, Vol. 65 Issue 2, p189 

    The article discusses research on the evidence for risk stratification of patients with Barrett's oesophagus (BO) according to BO length. It references a study by H. Pohl et al published within the issue. Topics covered include the estimated annual cancer transition rates in relation to...

  • The Feasibility of an Exercise Intervention in Males at Risk of Oesophageal Adenocarcinoma: A Randomized Controlled Trial. Winzer, Brooke M.; Paratz, Jennifer D.; Whitehead, Jonathan P.; Whiteman, David C.; Reeves, Marina M. // PLoS ONE;Feb2015, Vol. 10 Issue 2, p1 

    Objective: To investigate the feasibility and safety of a 24-week exercise intervention, compared to control, in males with Barrett’s oesophagus, and to estimate the effect of the intervention, compared to control, on risk factors associated with oesophageal adenocarcinoma development....

  • Gastro-Esophageal Reflux Disease Symptoms and Demographic Factors as a Pre-Screening Tool for Barrett’s Esophagus. Liu, Xinxue; Wong, Angela; Kadri, Sudarshan R.; Corovic, Andrej; O’Donovan, Maria; Lao-Sirieix, Pierre; Lovat, Laurence B.; Burnham, Rodney W.; Fitzgerald, Rebecca C. // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Background: Barrett’s esophagus (BE) occurs as consequence of reflux and is a risk factor for esophageal adenocarcinoma. The current “gold-standard” for diagnosing BE is endoscopy which remains prohibitively expensive and impractical as a population screening tool. We aimed to...

  • Diagnosis and treatment of Barrett's oesophagus. Lim, Yean Cheant; Fitzgerald, Rebecca C. // British Medical Bulletin;Sep2013, Vol. 107 Issue 1, p117 

    Introduction Barrett's oesophagus (BO) is a common premalignant condition, which carries a risk of progression to oesophageal adenocarcinoma. Recent advances include quantifying the risk of neoplasia progression, novel diagnostic tools and development of new endoscopic techniques to treat early...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics